Chugai Pharmaceutical Co Ltd logo

Chugai Pharmaceutical Co Ltd

CHGCY · OTC · Pharmaceuticals, Biotech · Founded 1925

Chugai Pharmaceutical Co., Ltd. (中外製薬株式会社, Chūgai Seiyaku kabushiki gaisha) is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo.

Current Price
$21.52
Market Cap
$71.4B
Return Since Last Split
-18%
Last Split
Jul 6, 2020
Total Splits
1
Cumulative Multiple
12×

What If You Bought CHGCY Earlier?

Investment
Purchase Date (Before Split)
Worth Today
$25,824
1,200 shares · 12×

Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.

Stock Split History

Newest split first. Cumulative multiple = compounded growth within the displayed company lineage.

Split DatePrice BeforeRatioSplit MultipleCumulative
Jul 6, 2020$26.7112-for-112×12×

Chugai Pharmaceutical Co Ltd Market Cap Timeline

Validated annual market-cap history is available from 2003. Split markers cover 1 current-security split. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.

Frequently Asked Questions

Chugai Pharmaceutical Co Ltd's latest record in the split calendar is a 12-for-1 forward split effective 2020-07-06.
Stay in the loop

Never Miss a Stock Split Again

Get personalized stock split alerts. Choose what you receive and how often.

Your email is securely stored. We’ll only contact you about updates you choose. Unsubscribe anytime.